• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.03% Nasdaq Up0.33%

    Raptor Pharmaceuticals Corp. (RPTP)

    -NasdaqGM
    14.13 Down 0.06(0.42%) Jul 30, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 20,453   17,286   23,764   16,313  
    Cost of Revenue3,722  3,190  3,917  995  
    Gross Profit 16,731   14,096   19,847   15,318  
    Operating Expenses
    Research Development16,552  13,852  9,001  11,077  
    Selling General and Administrative14,839  16,186  15,078  13,326  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (14,660) (15,942) (4,232) (9,085)
    Income from Continuing Operations
    Total Other Income/Expenses Net(504)184  2,571  (105)
    Earnings Before Interest And Taxes(15,164)(15,758)(1,661)(9,190)
    Interest Expense4,498  3,115  4,380  3,497  
    Income Before Tax(19,662)(18,873)(6,041)(12,687)
    Income Tax Expense21  50  (8)6  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(19,683)(18,923)(6,033)(12,693)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (19,683) (18,923) (6,033) (12,693)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (19,683) (18,923) (6,033) (12,693)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.